Free-roaming dogs are removed from the street by the Municipal Animal Control division/shelter and NGOs to safeguard public health as well as to prevent any suffering dogs may face and to find them homes. However, adoption rates are low and there is a lack of public programs aimed at humane control causing increased numbers of street dogs and overcrowding in shelters, compromising health and welfare. We aimed to evaluate the health of dogs from municipal shelters and independent shelters, and community dogs in the city of Guarapuava through clinical examination and complete blood cell count tests.
View Article and Find Full Text PDFThe case of a 9-month-old boy with an initial diagnosis of atopic dermatitis and confirmed allergy to hen's egg, cow's milk allergens with episodes of anaphylaxis who developed birch allergy whilst under observation with asthma symptoms was presented. The precision allergy molecular diagnosis (PAMD @) allowed for individualisation of dietary recommendations and observing the early progression of food sensitisation to the main birch molecule. The presented identification of major allergic molecules with PAMD@ in the preclinical phase of asthma contributes to the discussion related to early specific immunotherapy to suppress molecular spread and allergic march.
View Article and Find Full Text PDFBackground: Concerns associated with blended enteral feeds include the risk of blocked tubes and microbial contamination, although the available evidence is limited. The present laboratory-based investigation aimed to examine these risks in a blended feed providing a nutritionally adequate intake for a hypothetical patient.
Methods: A one-blended feed recipe was made using three different methods (professional, jug and stick blenders) and three storage procedures.
The Aim Of The Study: Assessment of clinical and endoscopic efficacy of induction therapy with infliximab in children with ulcerative colitis.
Material And Methods: This is a retrospective analysis of medical records of pediatric patients with moderate to severe UC who had received at least one infusion of infliximab in Polish pediatric academic clinical centers from 2003 to 2013. The primary endpoint was clinical remission rate at week 10, (PUCAI score <10 points) while the secondary endpoints were: clinical response rate (>19-points decrease in PUCAI), mucosal response rate (defined as an improvement of the Baron score), and mucosal healing rate (Baron score 0 or 1).